Rare immune toxicities can be fatal—but timely recognition and aggressive care can change the outcome.
When the scan isn’t the whole story, a biopsy can rewrite the ending.
The CHALLENGE trial proves what we’ve long suspected: structured exercise isn’t just good for you—it can save your life.
Cannabis can ease the journey through cancer treatment—but it is not without risks, especially when it comes to immunotherapy.
AI in medicine isn’t about replacing us—it’s about giving us back the time to be fully present, both with our patients and in our lives.
Coming home is less about geography and more about gratitude for the life we’re building, one step at a time.
A five-minute call with your oncology expert can save weeks of wasted time—and prevent costly missteps.
When immune therapy clears cancer, the real question for resectable tumors becomes: Do we still need to resect?
From early-stage to brain metastases, ASCO’s latest melanoma abstracts spotlight the growing power of targeted and immune-based therapies across disease stages.
ctDNA is helping us track what truly matters—real-time, personalized signals that guide smarter decisions in cancer care.